WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Shares Gap Up – Here’s Why
by Scott Moore · The Cerbat GemWuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report)’s share price gapped up prior to trading on Thursday . The stock had previously closed at $12.20, but opened at $12.5899. WuXi Biologics (Cayman) shares last traded at $11.93, with a volume of 425 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, Zacks Research upgraded WuXi Biologics (Cayman) to a “hold” rating in a research note on Friday, August 28th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, WuXi Biologics (Cayman) presently has a consensus rating of “Hold”.
Check Out Our Latest Stock Analysis on WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Price Performance
The stock’s 50 day simple moving average is $11.00 and its 200 day simple moving average is $9.51.
WuXi Biologics (Cayman) Company Profile
WuXi Biologics (Cayman) is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company provides integrated services to pharmaceutical and biotechnology customers across the development cycle, from early-stage discovery and preclinical research through clinical development, regulatory support and commercial manufacturing.
Its capabilities include the development and production of monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates and other biologic modalities.
Recommended Stories
- Five stocks we like better than WuXi Biologics (Cayman)
- Insider Sales Eclipse $450M Across 3 AI Winners, With NVIDIA Leading the Pack
- GameStop’s Comeback Case Is Getting Interesting, But eBay Still Looks Stronger
- Why Braze’s Guidance Miss May Be a Gift for Investors
- This Corner of the Market Is Outperforming the Benchmark—And It’s Not AI